What is an Evidence Summary?
Key messages from scientific research that's ready to be acted on
Got It, Hide this
In people with COPD, pulmonary rehabilitation reduces anxiety and depression symptoms
Gordon CS, Waller JW, Cook RM, et al. Effect of Pulmonary Rehabilitation on Symptoms of Anxiety and Depression in COPD: A Systematic Review and Meta-Analysis. Chest. 2019;156:80-91.
In people with chronic obstructive pulmonary disease (COPD), does pulmonary rehabilitation reduce symptoms of anxiety or depression?
COPD is a lung disease that affects your ability to breathe. Pulmonary rehabilitation is a treatment for COPD. It can help to improve outcomes such as ability to exercise and quality of life. People with COPD often also have anxiety or depression. This review looks at whether pulmonary rehabilitation can improve symptoms of anxiety or depression in people who have COPD.
How the review was done
The researchers did a systematic review of studies available up to February 2018. They found 11 randomized controlled trials that included 734 people. Most people were men and were older than 60 years of age.
The key features of the studies were:
- people were outpatients who had COPD;
- studies compared pulmonary rehabilitation lasting 4 to 16 weeks with usual care;
- pulmonary rehabilitation included exercise training; it may or may not have also included education or psychological support; and
- most people had pulmonary rehabilitation 3 times each week for 4 to 8 weeks.
What the researchers found
Compared with usual care, pulmonary rehabilitation:
- reduced depression symptoms by a large amount; and
- reduced anxiety symptoms by a moderate amount.
In people with chronic obstructive pulmonary disease, pulmonary rehabilitation lasting for 4 to 16 weeks reduces anxiety and depression symptoms compared with usual care.
Effects of pulmonary rehabilitation vs usual care in adults with chronic obstructive pulmonary disease
10 trials (582 people)
Reduced anxiety scores by a moderate amount (about −2.2 points on the HADS Anxiety subscale)
10 trials (582 people)
Reduced depression scores by a large amount (about −2.5 points on the HADS Depression subscale)
Randomized controlled trials
Studies where people are assigned to one of the treatments purely by chance.
A comprehensive evaluation of the available research evidence on a particular topic.
Related Evidence Summaries
Cadernos de Saúde Pública (2016)
Cochrane Database of Systematic Reviews (2016)
Cochrane Database of Systematic Reviews (2013)
Related Web Resources
Canadian Task Force on Preventive Health Care
If you are between 55 and 74 and are currently or used to be a smoker, you should consider getting tested for lung cancer. You should speak with your health care provider about getting tested using a low-dose CT scan once a year for three years.
Poor housing is associated with poor health. Research shows cold, damp and overcrowded homes can have a negative impact on your respiratory health.
Long-acting muscarinic antagonists (LAMAs) may help to treat poorly-controlled asthma in adults. More research is needed. Work with your doctor to find a treatment that is best for you.
DISCLAIMER These summaries are provided for informational purposes only. They are not a substitute for advice from your own health care professional. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the McMaster Optimal Aging Portal